Cogent Biosciences, Inc.

Cogent Biosciences, Inc.verified

COGT

Price:

$8.5

Market Cap:

$812.71M

Cogent Biosciences, Inc., a biotechnology company, focuses on developing precision therapies for genetically defined diseases. Its lead product candidate includes CGT9486, a selective tyrosine kinase inhibitor designed to inhibit the KIT D816V mutation that drives systemic mastocytosis, as well as other mutations in KIT exon 17, which are found in patients with advanced gastrointestinal stromal tumors. It has a licensing agreement with Plexxikon Inc. for the research, development, and commercialization of bezuclastinib. The company was formerly known as Unum Therapeutics Inc. and changed its name to Cogent Biosciences, Inc. in October 2020. Cogent Biosciences, Inc. was incorporated in 2014 a...[Read more]

Industry

Biotechnology

IPO Date

2018-03-29

Stock Exchange

NASDAQ

Ticker

COGT

The PE Ratio as of June 2024 (TTM) for Cogent Biosciences, Inc. (COGT) is -3.41

According to Cogent Biosciences, Inc.’s latest financial reports and current stock price. The company's current PE Ratio is -3.41. This represents a change of -2.30% compared to the average of -3.49 of the last 4 quarters.

Cogent Biosciences, Inc. (COGT) Historical PE Ratio (quarterly & annually)

How has COGT PE Ratio performed in the past?

The mean historical PE Ratio of Cogent Biosciences, Inc. over the last ten years is -3.73. The current -3.41 PE Ratio has changed 9.04% with respect to the historical average. Over the past ten years (40 quarters), COGT's PE Ratio was at its highest in in the December 2019 quarter at 2.40. The PE Ratio was at its lowest in in the June 2018 quarter at -11.59.

Quarterly (TTM)
Annual

Average

-3.73

Median

-3.17

Minimum

-9.24

Maximum

-0.72

Cogent Biosciences, Inc. (COGT) PE Ratio by Quarter and Year

Discovering the peaks and valleys of Cogent Biosciences, Inc. PE Ratio, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Maximum Annual Increase = 158.33%

Maximum Annual PE Ratio = -0.72

Minimum Annual Increase = -77.15%

Minimum Annual PE Ratio = -9.24

Quarterly (TTM)
Annual
YearPE RatioChange
2023-2.43-52.45%
2022-5.1210.62%
2021-4.63147.12%
2020-1.87158.33%
2019-0.72-77.15%
2018-3.175.12%
2017-3.02-10.19%
2016-3.36-63.63%

Cogent Biosciences, Inc. (COGT) Average PE Ratio

How has COGT PE Ratio performed in the past?

The current PE Ratio of Cogent Biosciences, Inc. (COGT) is greater than its 3-year, less than than its 5-year, and greater than its 10-year historical averages

3-year avg

-4.06

5-year avg

-2.96

10-year avg

-3.73

Cogent Biosciences, Inc. (COGT) PE Ratio vs. Peers

How is COGT’s PE Ratio compared to its peers?

Cogent Biosciences, Inc.’s PE Ratio is greater than Larimar Therapeutics, Inc. (-9.35), greater than Kura Oncology, Inc. (-9.87), less than Kiniksa Pharmaceuticals, Ltd. (148.62), greater than Cerevel Therapeutics Holdings, Inc. (-16.51), greater than IDEAYA Biosciences, Inc. (-21.72), greater than AnaptysBio, Inc. (-3.76), greater than MeiraGTx Holdings plc (-3.69), greater than Keros Therapeutics, Inc. (-8.20), less than Homology Medicines, Inc. (-0.01), greater than Sana Biotechnology, Inc. (-4.00), greater than Olema Pharmaceuticals, Inc. (-6.71), greater than Cullinan Oncology, Inc. (-5.46), less than aTyr Pharma, Inc. (-2.33), less than Zentalis Pharmaceuticals, Inc. (-1.34), greater than Syndax Pharmaceuticals, Inc. (-6.75), less than KalVista Pharmaceuticals, Inc. (-3.24), less than Mersana Therapeutics, Inc. (-1.84), less than Ventyx Biosciences, Inc. (-0.88), less than Protagonist Therapeutics, Inc. (12.23), greater than Verona Pharma plc (-19.69),

Build a custom stock screener for Cogent Biosciences, Inc. (COGT) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Cogent Biosciences, Inc. using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Custom stock screener in Wisesheets

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

Cogent Biosciences, Inc. (COGT) and other stocks custom spreadsheet templates

The easiest way to analyze a company like Cogent Biosciences, Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Custom stock templates in Wisesheets

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.

Frequently asked questions❓

What is the PE Ratio?

How can you use the PE Ratio?

What is Cogent Biosciences, Inc.'s PE Ratio?

How is the PE Ratio calculated for Cogent Biosciences, Inc. (COGT)?

What is the highest PE Ratio for Cogent Biosciences, Inc. (COGT)?

What is the 3-year average PE Ratio for Cogent Biosciences, Inc. (COGT)?

What is the 5-year average PE Ratio for Cogent Biosciences, Inc. (COGT)?

How does the current PE Ratio for Cogent Biosciences, Inc. (COGT) compare to its historical average?